AVLN
AvalynDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
$31.62+$0.45 (+1.44%)
At close · 2026-11-11
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AVLN vs peer average
44/100
AVLN vs. peer average (D vs. D)
Grade spread
B 1 · C 2 · D 4 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
TSHA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.39B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AVLN
Avalyn
TSHA
Taysha Gene Therapies
Grade
D
D
Momentum
41
11
Value
46
41
Sentiment
-
60
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs TSHA
AVLN / TSHA
Grade Position
Below peers
AVLN vs. peer average (D vs. D)
44/100
Momentum
41
AVLNValue
46
AVLNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AVLN
TSHA is the first peer returned for this comparison set.